I had a read through their prospectus, the latest company review and their company presentation, they have been operating at a loss for the past 3 years. Their review mentioned that they hoped to breakeven by some point in 2016 (image attached). Given this information, would you still invest in a company like this, even though their closest competitors do not offer similar products?
Genetic Signatures (GSS) IPO
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.005(0.74%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 70.0¢ | 67.5¢ | $16.68K | 24.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27724 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 15574 | 2 |
View Market Depth
| Last trade - 14.24pm 03/12/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
